February 2020 issue of the ISEBTT Newsletter has been published

By |2020-04-09T20:41:36+01:00January 31st, 2020|

Electroporation had been instrumental in many different areas and new applications are being constantly developed.

Just last week, Medtronic received FDA approval to test electroporation as an ablation method for treatment of atrial fibrillation

The expectations are high, as described in the report from the AF Symposium (www.afsymposium.com) in this month’s Newsletter.

External Link:

Other/all issues available here

Keywords: newsletter; tissue ablation;

Go to Top